← FDA Drug Approvals (Drugs@FDA)
RYLAZE
BLA · Biologics License Application · Sponsor: JAZZ PHARMS · Approved 2021-06-30
Drug application
- FDA Application #
BLA761179- Application type
- Biologics License Application
- Brand name
- RYLAZE
- Generic name
- ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN
- Active ingredients
- ASPARAGINASE ERWINIA CHRYSANTHEMI (RECOMBINANT)-RYWN
- Dosage form
- INJECTABLE
- Route
- INTRAMUSCULAR
- Marketing status
- Prescription
- Sponsor
- JAZZ PHARMS
- Manufacturer
- Jazz Pharmaceuticals, Inc.
- First approval
- 2021-06-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown